Literature DB >> 18554695

Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years.

J Kellogg Parsons1, Jaclyn Bergstrom, Jonathan Silberstein, Elizabeth Barrett-Connor.   

Abstract

OBJECTIVES: We analyzed the prevalence and characteristics of lower urinary tract symptoms (LUTS) in community-dwelling men aged 80 years and older.
METHODS: We administered the American Urological Association Symptom Index (AUA-SI) by mail to 291 surviving community-dwelling male participants in the Rancho Bernardo Study, a prospective, community-based study of aging. We compared the prevalence, severity, and types of LUTS occurring in men who were > or = 80 years to those < 80 years.
RESULTS: The mean age was 74.6 years (standard deviation [SD] 8.9, range 48.3-97.1). One third of the respondents were > or = 80 years. The mean total AUA-SI score increased steadily by decade of life (P-trend = .002). The prevalence of LUTS was 70% in men > or = 80 years and 56% in men < 80 years (P = .03). Men > or = 80 years had significantly higher mean total AUA-SI (P = .05) and were more likely to complain of incomplete emptying (odds ratio [OR] 2.12, 95% confidence interval [CI] 1.06-4.18, P = .02), frequency (OR 1.83, 95% CI 1.00-3.31, P = .03), urgency (OR 1.76, 95% CI 0.96-3.20, P = .05), and weak stream (OR 1.78, 95% CI 1.01-3.12, P = .03).
CONCLUSIONS: In this cohort of community-dwelling men, prevalence and severity of LUTS increased into the 10th decade of life. Compared to younger men, men > or = 80 years were more likely to complain of incomplete emptying, frequency, urgency, and weak stream. Further studies of LUTS in older men are needed to better delineate these associations.

Entities:  

Mesh:

Year:  2008        PMID: 18554695      PMCID: PMC2597492          DOI: 10.1016/j.urology.2008.03.057

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Trends in aging--United States and worldwide.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-02-14       Impact factor: 17.586

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.

Authors:  P Trueman; S C Hood; U S Nayak; M F Mrazek
Journal:  BJU Int       Date:  1999-03       Impact factor: 5.588

4.  Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; John T Wei; Michael P O'Leary; John W Kusek; Heather J Litman; Carol L Link; John B McKinlay
Journal:  Arch Intern Med       Date:  2006-11-27

5.  Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.

Authors:  Garry Welch; Katie Weinger; Michael J Barry
Journal:  Urology       Date:  2002-02       Impact factor: 2.649

6.  Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study.

Authors:  Brent C Taylor; Timothy J Wilt; Howard A Fink; Lori C Lambert; Lynn M Marshall; Andrew R Hoffman; Tomasz M Beer; Douglas C Bauer; Joseph M Zmuda; Eric S Orwoll
Journal:  Urology       Date:  2006-10       Impact factor: 2.649

7.  Economic costs of benign prostatic hyperplasia in the private sector.

Authors:  Christopher S Saigal; Geoffrey Joyce
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

8.  Urologic diseases in America project: benign prostatic hyperplasia.

Authors:  John T Wei; Elizabeth Calhoun; Steven J Jacobsen
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

9.  The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study.

Authors:  P Boyle; C Robertson; C Mazzetta; M Keech; F D R Hobbs; R Fourcade; L Kiemeney; C Lee
Journal:  BJU Int       Date:  2003-09       Impact factor: 5.588

  9 in total
  52 in total

1.  Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men.

Authors:  Sean A Martin; Matthew T Haren; Villis R Marshall; Kylie Lange; Gary A Wittert
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

2.  Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.

Authors:  Petra Popovics; Wisam N Awadallah; Sarah E Kohrt; Thomas C Case; Nicole L Miller; Emily A Ricke; Wei Huang; Marisol Ramirez-Solano; Qi Liu; Chad M Vezina; Robert J Matusik; William A Ricke; Magdalena M Grabowska
Journal:  Prostate       Date:  2020-05-01       Impact factor: 4.104

3.  Lower Urinary Tract Symptoms and Risk of Nonspine Fractures among Older Community Dwelling U.S. Men.

Authors:  Lynn M Marshall; Jodi A Lapidus; Jack Wiedrick; Elizabeth Barrett-Connor; Douglas C Bauer; Eric S Orwoll; J Kellogg Parsons
Journal:  J Urol       Date:  2016-02-22       Impact factor: 7.450

Review 4.  [Bladder storage and voiding dysfunctions : Side effects of drug therapy].

Authors:  J Wolfesberger; C E Falkensammer; S Madersbacher
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

Review 5.  Combination pharmacological therapies for the management of benign prostatic hyperplasia.

Authors:  Seth A Cohen; J Kellogg Parsons
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

Review 6.  Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Authors:  Linda Vignozzi; Mauro Gacci; Mario Maggi
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

7.  Associations between modest weight changes and onset and progression of lower urinary tract symptoms in two population-based cohorts.

Authors:  Jennifer L St Sauver; Aruna V Sarma; John M Hollingsworth; Debra J Jacobson; Michaela E McGree; Rodney L Dunn; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2011-06-15       Impact factor: 2.649

Review 8.  Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction.

Authors:  Yana Barbalat; Marissa C Velez; Christopher I Sayegh; Doreen E Chung
Journal:  Ther Adv Urol       Date:  2016-02-24

9.  The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.

Authors:  Ryan P Kopp; Lynn M Marshall; Patty Y Wang; Douglas C Bauer; Elizabeth Barrett-Connor; J Kellogg Parsons
Journal:  Eur Urol       Date:  2013-04-03       Impact factor: 20.096

10.  Prostatic fibrosis is associated with lower urinary tract symptoms.

Authors:  Jinjin Ma; Mehrnaz Gharaee-Kermani; Lakshmi Kunju; John M Hollingsworth; Jeremy Adler; Ellen M Arruda; Jill A Macoska
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.